These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17178109

  • 1. Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin.
    Harada K, Okiyoneda T, Hashimoto Y, Oyokawa K, Nakamura K, Suico MA, Shuto T, Kai H.
    Biochem Biophys Res Commun; 2007 Feb 09; 353(2):351-6. PubMed ID: 17178109
    [Abstract] [Full Text] [Related]

  • 2. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.
    Lipecka J, Norez C, Bensalem N, Baudouin-Legros M, Planelles G, Becq F, Edelman A, Davezac N.
    J Pharmacol Exp Ther; 2006 May 09; 317(2):500-5. PubMed ID: 16424149
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells.
    Dragomir A, Björstad J, Hjelte L, Roomans GM.
    Biochem Biophys Res Commun; 2004 Sep 17; 322(2):447-51. PubMed ID: 15325250
    [Abstract] [Full Text] [Related]

  • 5. Surface expression of the cystic fibrosis transmembrane conductance regulator mutant DeltaF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature.
    Heda GD, Marino CR.
    Biochem Biophys Res Commun; 2000 May 19; 271(3):659-64. PubMed ID: 10814518
    [Abstract] [Full Text] [Related]

  • 6. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane.
    Young A, Gentzsch M, Abban CY, Jia Y, Meneses PI, Bridges RJ, Bradbury NA.
    Biochem J; 2009 Jul 15; 421(3):377-85. PubMed ID: 19442237
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells.
    Zaman K, Carraro S, Doherty J, Henderson EM, Lendermon E, Liu L, Verghese G, Zigler M, Ross M, Park E, Palmer LA, Doctor A, Stamler JS, Gaston B.
    Mol Pharmacol; 2006 Oct 15; 70(4):1435-42. PubMed ID: 16857740
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological and signaling properties of endogenous P2Y1 receptors in cystic fibrosis transmembrane conductance regulator-expressing Chinese hamster ovary cells.
    Marcet B, Chappe V, Delmas P, Verrier B.
    J Pharmacol Exp Ther; 2004 May 15; 309(2):533-9. PubMed ID: 14742736
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Maintaining low Ca2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells.
    Norez C, Antigny F, Becq F, Vandebrouck C.
    Traffic; 2006 May 15; 7(5):562-73. PubMed ID: 16643279
    [Abstract] [Full Text] [Related]

  • 13. Diffusional mobility of the cystic fibrosis transmembrane conductance regulator mutant, delta F508-CFTR, in the endoplasmic reticulum measured by photobleaching of GFP-CFTR chimeras.
    Haggie PM, Stanton BA, Verkman AS.
    J Biol Chem; 2002 May 10; 277(19):16419-25. PubMed ID: 11877404
    [Abstract] [Full Text] [Related]

  • 14. Low temperature induces the delivery of mature and immature CFTR to the plasma membrane.
    Rennolds J, Boyaka PN, Bellis SL, Cormet-Boyaka E.
    Biochem Biophys Res Commun; 2008 Feb 22; 366(4):1025-9. PubMed ID: 18096515
    [Abstract] [Full Text] [Related]

  • 15. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
    Routaboul C, Norez C, Melin P, Molina MC, Boucherle B, Bossard F, Noel S, Robert R, Gauthier C, Becq F, Décout JL.
    J Pharmacol Exp Ther; 2007 Sep 22; 322(3):1023-35. PubMed ID: 17578899
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.
    Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glöckner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ.
    Science; 2004 Apr 23; 304(5670):600-2. PubMed ID: 15105504
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Trafficking of immature DeltaF508-CFTR to the plasma membrane and its detection by biotinylation.
    Luo Y, McDonald K, Hanrahan JW.
    Biochem J; 2009 Apr 01; 419(1):211-9, 2 p following 219. PubMed ID: 19053947
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.